Report updated May 5, 2026
Top 200 Drugs Study
For healthcare students, pharmacy technicians, and medical professionals preparing for board exams or requiring quick pharmacology reference.
Top 200 Drugs Study is a struggling education app that is a paid app. With a 3.0/5 rating from 2 reviews, it struggles with user retention.
What is Top 200 Drugs Study?
Top 200 Drugs Study is a mobile flashcard and quiz application for healthcare students and professionals.
Users hire the app to master pharmacology for board exams via active recall, but the current content decay prevents it from serving as a reliable clinical reference.
Current Momentum
v3.0 · 12mo ago
Maintenance- Added favorites feature to flash cards.
- Added pharmacology short articles.
- Added email-exportable Cheat Sheet.
What makes this app unique?
What Are The Key Features?
Nine question types covering 1800+ cards with customizable deck sizes and favorite save functionality
Searchable drug database with Wikipedia integration for detailed pharmaceutical information
Multiple-choice testing with randomized answers and progress tracking for active recall
Custom study set creation for specific medication groups or exam preparation
Quick pharmacology topics exportable via text and email
How much does it cost?
- One-time purchase at $1.99
The app utilizes a low-cost, one-time purchase model, positioning it as an accessible utility for students and professionals.
Who Built It?
Polemics Applications
Providing U.S. military personnel with offline-first tactical references and administrative tools for field and garrison environments.
Portfolio
13
Apps
What other apps does Polemics Applications make?
Explore the full Polemics Applications report
Portfolio breakdown, audience, momentum, and every app published by Polemics Applications.
What do users think recently?
Low confidence · 1 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. but report outdated medical information in the current version prevents professional use for clinical reference.
Limited review volume (1 reviews). Sentiment analysis will deepen as more data lands.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Top 200 Drugs Study?
How's The Education Market?
Market outlook for this category
Available very soon
The rivals identified
Nemeses(1)
This is the primary direct rival due to its specialized focus on medication reference, high-frequency updates, and established authority in the medical domain.
Differentiators
- Maintains a comprehensive, professionally curated drug database that serves as a primary source of truth for clinicians.
- Offers deep integration with clinical decision support tools that go far beyond simple flashcard-based study aids.
- Provides real-time medication safety alerts and interaction checkers that provide immediate utility to practicing healthcare professionals.
Head to head
The target app must pivot toward specialized student-focused features like spaced-repetition algorithms to differentiate from the clinical reference utility of Drugs.com.
Contenders(2)
A massive incumbent in the medical space that provides a broader suite of tools including news and clinical reference.
Differentiators
- Integrates daily medical news and professional education modules alongside standard drug reference databases.
- Provides a comprehensive ecosystem that supports the entire career lifecycle of a healthcare professional.
Directly competes for the same student audience by utilizing visual mnemonic learning strategies for medical pharmacology.
Differentiators
- Utilizes proprietary visual mnemonic storytelling to improve long-term retention of complex pharmacological concepts.
- Offers specialized content tracks tailored specifically for nursing students and NCLEX exam preparation requirements.
Same space(2)
The gold standard for serious medical students using spaced-repetition systems for high-volume pharmacology memorization.
Differentiators
- Features a highly sophisticated, open-source spaced-repetition algorithm that is the industry standard for medical board prep.
- Supports complex media types and custom card templates that allow for deep customization of study materials.
A dominant general-purpose study platform that competes for the same student time-share via user-generated flashcard decks.
Differentiators
- Leverages massive network effects through millions of user-created study sets across every academic discipline.
- Provides advanced AI-powered study modes that adapt to user performance and specific learning gaps.
New entrants(1)
Represents the shift toward AI-automated study material generation, threatening static flashcard apps with dynamic content creation.
Differentiators
- Automatically generates study flashcards and summaries from uploaded lecture recordings or long-form PDF documents.
- Reduces the manual effort of deck creation by using generative AI to extract key pharmacological concepts.
Compare Top 200 Drugs Study against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Top 200 Drugs Study
Strengths to defend, gaps to attack
Core Strengths
- Distraction-free interface optimizes for rapid study sessions
- Cheat Sheet export enables viral distribution among student cohorts
Critical Frictions
- Content decay renders the database unreliable for clinical use
- 3.0-star rating reflects user frustration with outdated medication lists
Growth Levers
- Integrate AI-driven deck generation to compete with Turbo AI
- Pivot to a subscription model to fund continuous clinical database updates
Market Threats
- Drugs.com's high-velocity update cadence makes manual database maintenance unsustainable
- AI-automated study tools reduce the value of static, pre-built flashcard decks
What are the next best moves?
Audit and refresh the drug database because current content is outdated → restore professional trust
User complaints highlight the exclusion of modern medications and inclusion of discontinued drugs.
Trade-off: Pause the development of new quiz modes; content accuracy is the primary churn driver.
Implement AI-automated study set generation because competitors like Turbo AI are reducing manual effort → maintain competitive parity
The current manual deck creation is a friction point compared to emerging AI-native study tools.
Trade-off: Deprioritize the UI color palette maintenance; functional automation provides higher user value.
A counter-intuitive read
The app's biggest risk is not the lack of features, but its reliance on manual content curation in an era where AI-automated study tools render static databases obsolete.
Feature Gaps vs Competitors
- Real-time clinical decision support (available in Drugs.com but absent here)
- AI-automated study set generation (available in Turbo AI but absent here)
- Visual mnemonic learning tracks (available in Picmonic but absent here)
Key Takeaways
The app provides a focused study environment but suffers from critical content decay, so the PM must prioritize a database audit to prevent total churn among the professional user base.
Where Is It Heading?
Declining
The pharmacology study market is shifting toward automated, high-velocity content delivery, leaving static apps like this one exposed. Without a pivot to automated updates or a subscription-funded content team, the app will continue to lose relevance to AI-native competitors.
Critical content decay in the latest version prevents professional use, which accelerates churn among the core student audience.
Manual database maintenance cannot keep pace with clinical standards, creating a widening trust gap against professional incumbents.